384 related articles for article (PubMed ID: 24299565)
1. Modulation of mucosal/systemic antibody response after sublingual immunotherapy in mite-allergic children.
Queirós MG; Silva DA; Siman IL; Ynoue LH; Araújo NS; Pereira FL; Almeida KC; Miranda JS; Pena JD; Cunha-Junior JP; Taketomi EA
Pediatr Allergy Immunol; 2013 Dec; 24(8):752-61. PubMed ID: 24299565
[TBL] [Abstract][Full Text] [Related]
2. Mite-specific immunotherapy using allergen and/or bacterial extracts in atopic patients in Brazil.
Guimarães Junqueir de Queirós M; Oliveira Silva DA; Alves R; Fukuhara Chiba H; Soares de Amaral VB; de Almeida KC; Ynoue LH; de Oliveira Resende R; Camargo Sopelete MC; Rodrigues Silva Segundo G; Ferreira de Sousa Moreira P; Sung SJ; Taketomi EA
J Investig Allergol Clin Immunol; 2008; 18(2):84-92. PubMed ID: 18447136
[TBL] [Abstract][Full Text] [Related]
3. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
[TBL] [Abstract][Full Text] [Related]
4. Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites.
Bahceciler NN; Arikan C; Taylor A; Akdis M; Blaser K; Barlan IB; Akdis CA
Int Arch Allergy Immunol; 2005 Mar; 136(3):287-94. PubMed ID: 15722639
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial.
Karakoc-Aydiner E; Eifan AO; Baris S; Gunay E; Akturk E; Akkoc T; Bahceciler NN; Barlan IB
J Investig Allergol Clin Immunol; 2015; 25(5):334-42. PubMed ID: 26727762
[TBL] [Abstract][Full Text] [Related]
6. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
Calderon MA; Casale TB; Nelson HS; Demoly P
J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
[TBL] [Abstract][Full Text] [Related]
8. Differential IgE reactivity to Der p 1 and Der p 2 allergens of Dermatophagoides pteronyssinus in mite-sensitized patients.
Taketomi EA; Silva DA; Sopelete MC; Gervásio AM; Alves R; Sung SJ
J Investig Allergol Clin Immunol; 2006; 16(2):104-9. PubMed ID: 16689183
[TBL] [Abstract][Full Text] [Related]
9. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
10. Serum and salivary IgE, IgA, and IgG4 antibodies to Dermatophagoides pteronyssinus and its major allergens, Der p1 and Der p2, in allergic and nonallergic children.
Miranda DO; Silva DA; Fernandes JF; Queirós MG; Chiba HF; Ynoue LH; Resende RO; Pena JD; Sung SS; Segundo GR; Taketomi EA
Clin Dev Immunol; 2011; 2011():302739. PubMed ID: 22007250
[TBL] [Abstract][Full Text] [Related]
11. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
Baron-Bodo V; Batard T; Nguyen H; Fréreux M; Horiot S; Harwanegg C; Bergmann KC; de Beaumont O; Moingeon P
Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
[TBL] [Abstract][Full Text] [Related]
12. Prolonged effect of allergen sublingual immunotherapy for house dust mites in elderly patients.
Bozek A; Starczewska-Dymek L; Jarzab J
Ann Allergy Asthma Immunol; 2017 Jul; 119(1):77-82. PubMed ID: 28668244
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma.
Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB
Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909
[TBL] [Abstract][Full Text] [Related]
14. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
[TBL] [Abstract][Full Text] [Related]
15. Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response.
Gallego MT; Iraola V; Himly M; Robinson DS; Badiola C; García-Robaina JC; Briza P; Carnés J
Int Arch Allergy Immunol; 2010; 153(1):61-9. PubMed ID: 20357486
[TBL] [Abstract][Full Text] [Related]
16. Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial.
Wang DH; Chen L; Cheng L; Li KN; Yuan H; Lu JH; Li H
Laryngoscope; 2013 Jun; 123(6):1334-40. PubMed ID: 23616386
[TBL] [Abstract][Full Text] [Related]
17. House dust mite sublingual immunotherapy: results of a US trial.
Bush RK; Swenson C; Fahlberg B; Evans MD; Esch R; Morris M; Busse WW
J Allergy Clin Immunol; 2011 Apr; 127(4):974-81.e1-7. PubMed ID: 21333346
[TBL] [Abstract][Full Text] [Related]
18. Component-resolved diagnosis with commercially available D. pteronyssinus Der p 1, Der p 2 and Der p 10: relevant markers for house dust mite allergy.
Bronnert M; Mancini J; Birnbaum J; Agabriel C; Liabeuf V; Porri F; Cleach I; Fabre A; Deneux I; Grandné V; Grob JJ; Berbis P; Charpin D; Bongrand P; Vitte J
Clin Exp Allergy; 2012 Sep; 42(9):1406-15). PubMed ID: 22747483
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].
Zhou L; Wang J; Chen Y; Luo R; Tao J; Nie M; Liu B; Li Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490
[TBL] [Abstract][Full Text] [Related]
20. Changes in serum specific IgG4 and IgG4/ IgE ratio in mite-sensitized Taiwanese children with allergic rhinitis receiving short-term sublingual-swallow immunotherapy: a multicenter, randomized, placebo-controlled trial.
Tseng SH; Fu LS; Nong BR; Weng JD; Shyur SD
Asian Pac J Allergy Immunol; 2008; 26(2-3):105-12. PubMed ID: 19054928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]